BFL-1 inhibitors (Walter and Eliza Hall Institute of Medical Research)

N/A

Report date: 2025/03/14 16:40:02
NME

Base Information

Drug NameBFL-1 inhibitors (Walter and Eliza Hall Institute of Medical Research)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcl-2-related protein A1 inhibitors
TargetsBcl-2-related protein A1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesWalter And Eliza Hall Institute Of Medical Research
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A